We are live on ! Find out more
DDC

Daniel Devine & Co Portfolio holdings

AUM $125M
1-Year Est. Return 14.12%
This Fund
S&P 500
This Quarter Est. Return
-8.6%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
-$4.27M
Cap. Flow
+$9.59M
Cap. Flow %
6.78%
Top 10 Hldgs %
57.32%
Holding
65
New
3
Increased
17
Reduced
3
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 9.91%
2 Industrials 9.75%
3 Technology 7.44%
4 Financials 5.16%
5 Materials 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$26.1M 18.49%
136,420
+11,678
+9% +$2.37M
QQQ icon
2
Invesco QQQ Trust
QQQ
$453B
$12.3M 8.73%
121,255
MDY icon
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$11.7M 8.3%
47,130
+150
+0.3% +$39.7K
AAPL icon
4
Apple
AAPL
$4.54T
$7.62M 5.39%
276,308
+12,064
+5% +$354K
OIH icon
5
VanEck Oil Services ETF
OIH
$2.06B
$4.85M 3.43%
8,823
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$4.51M 3.19%
48,282
+1,050
+2% +$102K
XLI icon
7
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$3.75M 2.65%
75,215
IBB icon
8
iShares Biotechnology ETF
IBB
$9.34B
$3.63M 2.57%
+35,910
New +$4.31M
GE icon
9
GE Aerospace
GE
$374B
$3.43M 2.43%
28,378
+316
+1% +$38.7K
EEM icon
10
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$3.04M 2.15%
92,830
V icon
11
Visa
V
$684B
$2.44M 1.73%
35,080
+1,400
+4% +$99.9K
ASH icon
12
Ashland
ASH
$3.33B
$2.33M 1.64%
47,227
+82
+0.2% +$4.46K
ECL icon
13
Ecolab
ECL
$78.1B
$2.17M 1.54%
19,820
CVX icon
14
Chevron
CVX
$392B
$2.07M 1.46%
26,260
+175
+0.7% +$14.7K
BA icon
15
Boeing
BA
$171B
$2.06M 1.46%
15,725
UNH icon
16
UnitedHealth
UNH
$376B
$1.98M 1.4%
+17,065
New +$2.04M
ZTS icon
17
Zoetis
ZTS
$32.4B
$1.9M 1.34%
46,044
TRN icon
18
Trinity Industries
TRN
$2.49B
$1.87M 1.32%
114,391
+1,389
+1% +$26.4K
GWW icon
19
W.W. Grainger
GWW
$65.3B
$1.79M 1.26%
8,315
EXPD icon
20
Expeditors International
EXPD
$22B
$1.77M 1.25%
37,675
ABBV icon
21
AbbVie
ABBV
$443B
$1.74M 1.23%
31,980
+2,175
+7% +$142K
BLK icon
22
Blackrock
BLK
$169B
$1.71M 1.21%
5,760
+35
+0.6% +$11.3K
FDX icon
23
FedEx
FDX
$72.7B
$1.68M 1.19%
11,667
+50
+0.4% +$7.98K
BX icon
24
Blackstone
BX
$102B
$1.62M 1.14%
52,020
+510
+1% +$18.4K
PFE icon
25
Pfizer
PFE
$143B
$1.58M 1.12%
53,046

Similar funds

Daniel Devine & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Daniel Devine & Co held 65 positions worth $141M, down 2.9% from $146M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Daniel Devine & Co deployed $9.59M of net new capital in Q3 2015, opening 3 new positions and adding to 17 existing holdings. Its largest new stake was iShares Biotechnology ETF: 35,910 shares worth $3.63M.

By sector, the portfolio is most concentrated in Healthcare at 9.9% of assets, up from 9% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $180K trimmed.

  • Daniel Devine & Co's largest Q3 2015 buy was iShares Biotechnology ETF: 35,910 shares worth $3.63M.
  • Daniel Devine & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $2.37M increase.
  • Daniel Devine & Co's biggest Q3 2015 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $180K.
  • Daniel Devine & Co fully exited Alerian MLP ETF in Q3 2015, selling an estimated $211K.
  • Daniel Devine & Co's ten largest holdings make up 57% of its $141M portfolio in Q3 2015.
  • Daniel Devine & Co opened 3 new positions and closed 1 in Q3 2015.
  • Daniel Devine & Co's portfolio value fell 2.9% quarter-over-quarter to $141M.

Based on Daniel Devine & Co's 13F filing for Q3 2015, filed 15 Oct 2015.